166 related articles for article (PubMed ID: 38176857)
1. Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial.
Matias-Guiu JA; González-Rosa J; Hernández MÁ; Martínez-Ginés ML; Portolés A; Pérez-Macías N; Benito-León J; Padrón I; Prieto J; Matias-Guiu J
BMJ Open; 2024 Jan; 14(1):e078661. PubMed ID: 38176857
[TBL] [Abstract][Full Text] [Related]
2. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
Nourbakhsh B; Revirajan N; Waubant E
Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
Nourbakhsh B; Revirajan N; Morris B; Cordano C; Creasman J; Manguinao M; Krysko K; Rutatangwa A; Auvray C; Aljarallah S; Jin C; Mowry E; McCulloch C; Waubant E
Lancet Neurol; 2021 Jan; 20(1):38-48. PubMed ID: 33242419
[TBL] [Abstract][Full Text] [Related]
4. Safety of low-intensity repetitive transcranial magneTic brAin stimUlation foR people living with mUltiple Sclerosis (TAURUS): study protocol for a randomised controlled trial.
Makowiecki K; Stevens N; Cullen CL; Zarghami A; Nguyen PT; Johnson L; Rodger J; Hinder MR; Barnett M; Young KM; Taylor BV
Trials; 2022 Aug; 23(1):626. PubMed ID: 35922816
[TBL] [Abstract][Full Text] [Related]
5. Amantadine for fatigue in multiple sclerosis.
Taus C; Giuliani G; Pucci E; D'Amico R; Solari A
Cochrane Database Syst Rev; 2003; (2):CD002818. PubMed ID: 12804439
[TBL] [Abstract][Full Text] [Related]
6. Amantadine for fatigue in multiple sclerosis.
Pucci E; Branãs P; D'Amico R; Giuliani G; Solari A; Taus C
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002818. PubMed ID: 17253480
[TBL] [Abstract][Full Text] [Related]
7. Effects of transcranial direct current stimulation on patients with post-stroke fatigue: a study protocol for a double-blind randomized controlled trial.
Sun X; Dong X; Yuan Q; Yu G; Shuai L; Ma C; Sun W
Trials; 2022 Mar; 23(1):200. PubMed ID: 35248120
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
[TBL] [Abstract][Full Text] [Related]
9. A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial.
De Keersmaecker AV; Van Doninck E; Popescu V; Willem L; Cambron M; Laureys G; D' Haeseleer M; Bjerke M; Roelant E; Lemmerling M; D'hooghe MB; Derdelinckx J; Reynders T; Willekens B
Front Immunol; 2024; 15():1362629. PubMed ID: 38680485
[TBL] [Abstract][Full Text] [Related]
10. Connectivity guided theta burst transcranial magnetic stimulation versus repetitive transcranial magnetic stimulation for treatment-resistant moderate to severe depression: study protocol for a randomised double-blind controlled trial (BRIGhTMIND).
Morriss R; Webster L; Abdelghani M; Auer DP; Barber S; Bates P; Blamire A; Briley PM; Brookes C; Iwabuchi S; James M; Kaylor-Hughes C; Lankappa S; Liddle P; McAllister-Williams H; O'Neill-Kerr A; Pszczolkowski Parraguez S; Suazo Di Paola A; Thomson L; Walters Y;
BMJ Open; 2020 Jul; 10(7):e038430. PubMed ID: 32641367
[TBL] [Abstract][Full Text] [Related]
11. REFRESH protocol: a non-inferiority randomised clinical trial comparing internet and teleconference to in-person 'Managing Fatigue' interventions on the impact of fatigue among persons with multiple sclerosis.
Plow M; Packer T; Mathiowetz VG; Preissner K; Ghahari S; Sattar A; Bethoux F; Finlayson M
BMJ Open; 2020 Aug; 10(8):e035470. PubMed ID: 32801193
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial.
Otte C; Chae WR; Nowacki J; Kaczmarczyk M; Piber D; Roepke S; Märschenz S; Lischewski S; Schmidt S; Ettrich B; Grabe HJ; Hegerl U; Hinkelmann K; Hofmann T; Janowitz D; Junghanns K; Kahl KG; Klein JP; Krueger THC; Leicht G; Prvulovic D; Reif A; Schoettle D; Strauss M; Westermair A; Friede T; Gold SM
BMJ Open; 2020 Dec; 10(12):e040119. PubMed ID: 33262189
[TBL] [Abstract][Full Text] [Related]
13. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
[TBL] [Abstract][Full Text] [Related]
14. Low-dose ketamine infusion for the treatment of multiple sclerosis fatigue (INKLING-MS): Study protocol for a randomized, double-blind, active placebo-controlled phase II trial.
Ghajarzadeh M; Roman S; Vega L; Nourbakhsh B
Contemp Clin Trials; 2023 Mar; 126():107106. PubMed ID: 36738917
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group.
Can J Neurol Sci; 1987 Aug; 14(3):273-8. PubMed ID: 2889518
[TBL] [Abstract][Full Text] [Related]
16. Effects of pulsed low-frequency magnetic field therapy on pain intensity in patients with musculoskeletal chronic low back pain: study protocol for a randomised double-blind placebo-controlled trial.
Abdulla FA; Alsaadi S; Sadat-Ali M; Alkhamis F; Alkawaja H; Lo S
BMJ Open; 2019 Jun; 9(6):e024650. PubMed ID: 31182440
[TBL] [Abstract][Full Text] [Related]
17. Dietary approaches to treat MS-related fatigue: comparing the modified Paleolithic (Wahls Elimination) and low saturated fat (Swank) diets on perceived fatigue in persons with relapsing-remitting multiple sclerosis: study protocol for a randomized controlled trial.
Wahls T; Scott MO; Alshare Z; Rubenstein L; Darling W; Carr L; Smith K; Chenard CA; LaRocca N; Snetselaar L
Trials; 2018 Jun; 19(1):309. PubMed ID: 29866196
[TBL] [Abstract][Full Text] [Related]
18. Effects of actual and imagined music-cued gait training on motor functioning and brain activity in people with multiple sclerosis: protocol of a randomised parallel multicentre trial.
Seebacher B; Helmlinger B; Pinter D; Ehling R; Hegen H; Ropele S; Reishofer G; Enzinger C; Brenneis C; Deisenhammer F
BMJ Open; 2022 Feb; 12(2):e056666. PubMed ID: 35131834
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
